UMR 177, IRD-CIRAD, CIRAD TA A-17/G, Campus International de Baillarguet, 34398 Montpellier Cedex 5, France.
BMC Microbiol. 2010 Jan 26;10:20. doi: 10.1186/1471-2180-10-20.
Human African trypanosomiasis is a lethal disease caused by the extracellular parasite Trypanosoma brucei. The proteins secreted by T. brucei inhibit the maturation of dendritic cells and their ability to induce lymphocytic allogenic responses. To better understand the pathogenic process, we combined different approaches to characterize these secreted proteins.
Overall, 444 proteins were identified using mass spectrometry, the largest parasite secretome described to date. Functional analysis of these proteins revealed a strong bias toward folding and degradation processes and to a lesser extent toward nucleotide metabolism. These features were shared by different strains of T. brucei, but distinguished the secretome from published T. brucei whole proteome or glycosome. In addition, several proteins had not been previously described in Trypanosoma and some constitute novel potential therapeutic targets or diagnostic markers. Interestingly, a high proportion of these secreted proteins are known to have alternative roles once secreted. Furthermore, bioinformatic analysis showed that a significant proportion of proteins in the secretome lack transit peptide and are probably not secreted through the classical sorting pathway. Membrane vesicles from secretion buffer and infested rat serum were purified on sucrose gradient and electron microscopy pictures have shown 50- to 100-nm vesicles budding from the coated plasma membrane. Mass spectrometry confirmed the presence of Trypanosoma proteins in these microvesicles, showing that an active exocytosis might occur beyond the flagellar pocket.
This study brings out several unexpected features of the secreted proteins and opens novel perspectives concerning the survival strategy of Trypanosoma as well as possible ways to control the disease. In addition, concordant lines of evidence support the original hypothesis of the involvement of microvesicle-like bodies in the survival strategy allowing Trypanosoma to exchange proteins at least between parasites and/or to manipulate the host immune system.
人类非洲锥虫病是一种由寄生虫锥虫布鲁斯氏引起的致命疾病。锥虫布鲁斯氏分泌的蛋白质会抑制树突状细胞的成熟及其诱导淋巴细胞同种异体反应的能力。为了更好地了解发病机制,我们结合了不同的方法来描述这些分泌蛋白。
通过质谱法共鉴定了 444 种蛋白质,这是迄今为止描述的最大的寄生虫分泌组。这些蛋白质的功能分析表明,它们强烈偏向于折叠和降解过程,而在核苷酸代谢方面的偏向较小。这些特征在不同的锥虫布鲁斯氏菌株中都存在,但将分泌组与已发表的锥虫布鲁斯氏全蛋白质组或糖体区分开来。此外,有几种蛋白质以前在锥虫中没有被描述过,其中一些构成了新的潜在治疗靶点或诊断标记物。有趣的是,这些分泌蛋白中有很大一部分在分泌后具有替代功能。此外,生物信息学分析表明,分泌组中很大一部分蛋白质缺乏转运肽,可能不是通过经典的分拣途径分泌的。从分泌缓冲液和受感染大鼠血清中纯化的膜泡在蔗糖梯度上,并通过电子显微镜观察到从有被质膜出芽的 50-100nm 囊泡。质谱法证实了这些微泡中存在锥虫蛋白,表明在鞭毛囊中可能会发生活跃的胞吐作用。
这项研究揭示了分泌蛋白的一些意外特征,并为锥虫的生存策略以及控制疾病的可能途径提供了新的视角。此外,一致的证据支持微泡样体参与生存策略的原始假设,这使得锥虫至少能够在寄生虫之间交换蛋白质,或者操纵宿主的免疫系统。